ATE415973T1 - Gemeinsame gabe von tigecyclin und digoxin - Google Patents

Gemeinsame gabe von tigecyclin und digoxin

Info

Publication number
ATE415973T1
ATE415973T1 AT05851251T AT05851251T ATE415973T1 AT E415973 T1 ATE415973 T1 AT E415973T1 AT 05851251 T AT05851251 T AT 05851251T AT 05851251 T AT05851251 T AT 05851251T AT E415973 T1 ATE415973 T1 AT E415973T1
Authority
AT
Austria
Prior art keywords
tigecycline
digoxin
joint administration
administration
joint
Prior art date
Application number
AT05851251T
Other languages
English (en)
Inventor
Donald Raible
Gopal Muralidharan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE415973T1 publication Critical patent/ATE415973T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
AT05851251T 2004-10-28 2005-10-24 Gemeinsame gabe von tigecyclin und digoxin ATE415973T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62285904P 2004-10-28 2004-10-28

Publications (1)

Publication Number Publication Date
ATE415973T1 true ATE415973T1 (de) 2008-12-15

Family

ID=36127476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05851251T ATE415973T1 (de) 2004-10-28 2005-10-24 Gemeinsame gabe von tigecyclin und digoxin

Country Status (18)

Country Link
US (1) US20060094668A1 (de)
EP (1) EP1804807B1 (de)
JP (1) JP2008518911A (de)
KR (1) KR20070069182A (de)
CN (1) CN101039679A (de)
AT (1) ATE415973T1 (de)
AU (1) AU2005310306A1 (de)
BR (1) BRPI0517406A (de)
CA (1) CA2582089A1 (de)
CR (1) CR9073A (de)
DE (1) DE602005011468D1 (de)
EC (1) ECSP077423A (de)
IL (1) IL182681A0 (de)
MX (1) MX2007005163A (de)
NO (1) NO20071706L (de)
RU (1) RU2007112409A (de)
WO (1) WO2006060084A2 (de)
ZA (1) ZA200703441B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102512429A (zh) 2005-03-14 2012-06-27 惠氏公司 替加环素组合物及制备方法
AR055336A1 (es) * 2005-06-16 2007-08-22 Wyeth Corp Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
US20100035845A1 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
MY199695A (en) 2017-01-27 2023-11-18 Neurocrine Biosciences Inc Methods for the administration of certain vmat2 inhibitors
DK3684333T3 (da) 2017-09-21 2025-05-12 Neurocrine Biosciences Inc Valbenazin-formulering med høj dosis og sammensætninger, fremgangsmåder og kits relateret hertil
US20200230127A1 (en) 2017-10-10 2020-07-23 Neurocrine Biosciences, Inc. Methods for the Administration of Certain VMAT2 Inhibitors

Also Published As

Publication number Publication date
WO2006060084A3 (en) 2006-07-20
NO20071706L (no) 2007-05-24
BRPI0517406A (pt) 2008-10-07
EP1804807A2 (de) 2007-07-11
CR9073A (es) 2007-08-28
ECSP077423A (es) 2007-05-30
RU2007112409A (ru) 2008-12-10
US20060094668A1 (en) 2006-05-04
IL182681A0 (en) 2007-09-20
AU2005310306A1 (en) 2006-06-08
JP2008518911A (ja) 2008-06-05
EP1804807B1 (de) 2008-12-03
CA2582089A1 (en) 2006-06-08
DE602005011468D1 (de) 2009-01-15
KR20070069182A (ko) 2007-07-02
CN101039679A (zh) 2007-09-19
MX2007005163A (es) 2007-06-26
WO2006060084A2 (en) 2006-06-08
ZA200703441B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
CY1124135T1 (el) Δοσολογικα σχηματα για την αγωγη της νοσου ρομρε
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
AR087003A1 (es) Dispositivo separador modular para el tratamiento de infecciones de la protesis de miembros humanos
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
EA201171186A1 (ru) Сокристалл этравирина и никотинамида
ZA200703441B (en) Coadministration of tigecycline and digoxin
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
CY1112121T1 (el) ΠΑΡΑΓΩΓΑ ΤΩΝ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-[1,2-α]-ΠΥΡΑΖΙΝ-6-ΚΑΡΒΟΞΑΜΙΔΙΩΝ ΚΑΙ ΤΩΝ 2,3,4,5-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-(1,2-α)-ΔΙΑΖΕΠΙΝ-7-ΚΑΡΒΟΞΑΜΙΔΙΩΝ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ
EA200400197A1 (ru) Способы получения поливалентных бактериофагов для лечения бактериальных инфекций
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
EA200602002A1 (ru) Применение спинозинов для заживления ран
GT200500266A (es) Nuevos derivados de pirimidina y su uso
ZA202300222B (en) Anti-αlpha-4-βeta-7 antibodies
DE60312494D1 (de) Optisch aktives pyridinderivat und medikament, das dieses enthält
WO2011106378A3 (en) Oral b12 therapy
ATE433459T1 (de) Desoxo-nonadepsipeptide
CO2023007851A2 (es) Proteínas de unión a il-7 y su uso en tratamientos médicos
NO20075508L (no) Stannsoporfinpreparater og administrering
RU2010140179A (ru) Способ лечения пародонтита - способ иорданишвили
EP4213938A4 (de) Therapeutische mittel und verwendungen davon
IL289616A (en) Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease
EP4185288A4 (de) Therapeutische mittel und verwendungen davon
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
RU2007136579A (ru) Способ лечения вич-инфицированных больных
RU2009105344A (ru) Способ лечения поствоспалительных хориоретинальных дистрофий

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties